论文部分内容阅读
本刊讯(记者侯玉岭高军)如何保证新版GMP按剂型分步实施,促进我国医药产业转型升级,是医药界“两会”代表委员集中关注的问题之一。全国人大代表、神威药业集团董事长李振江郑重建议国家食品药品监管局:深刻吸取
(Reporter Hou Yuling Gao Jun) How to ensure that the new version of GMP will be implemented step by step in accordance with the dosage form to promote the transformation and upgrading of China’s pharmaceutical industry is one of the issues that the medical profession’s “NPC and CPPCC” representatives have focused on. National People’s Congress, Shen Wei Pharmaceutical Group Chairman Li Zhenjiang solemnly proposed that the State Food and Drug Administration: a profound draw